Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LFMD
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Jessica Friedeman Chief Marketing Officer | LFMD LifeMD, Inc. | Sale | 15,000 | $3.61 | $54.1K Sale | Form 4 ↗ |
| Sep 10, 2025 | Nicholas P. Alvarez Chief Acquisition Officer | LFMD LifeMD, Inc. | Sale | 75,000 | $5.92 | $444.0K Sale | Form 4 ↗ |
| Jul 1, 2025 | Justin Schreiber Chairman and CEO, Director | LFMD LifeMD, Inc. | Sale | 25,000 | $9.99 | $249.8K Sale | Form 4 ↗ |
| Jul 1, 2025 | Justin Schreiber Chairman and CEO, Director | LFMD LifeMD, Inc. | Sale | 25,000 | $13.38 | $334.5K Sale | Form 4 ↗ |
| Jun 17, 2025 | Marc David Benathen Chief Financial Officer | LFMD LifeMD, Inc. | Sale | 50,000 | $14.01 | $700.5K Sale | Form 4 ↗ |
| Jun 16, 2025 | Marc David Benathen Chief Financial Officer | LFMD LifeMD, Inc. | Sale | 75,000 | $13.09 | $981.8K Sale | Form 4 ↗ |
| Jun 13, 2025 | Eric Harold Yecies Chief Legal Officer & GC | LFMD LifeMD, Inc. | Sale | 15,000 | $12.25 | $183.8K Sale | Form 4 ↗ |
| Jun 13, 2025 | Stefan Galluppi Chief Innovation Officer | LFMD LifeMD, Inc. | Sale | 85,000 | $12.38 | $1.1M Sale | Form 4 ↗ |
| Jun 2, 2025 | Justin Schreiber Chairman and CEO, Director | LFMD LifeMD, Inc. | Sale | 25,000 | $12.47 | $311.8K Sale | Form 4 ↗ |
| May 2, 2025 | Justin Schreiber Chairman and CEO, Director | LFMD LifeMD, Inc. | Sale | 3,005 | $7.50 | $22.5K Sale | Form 4 ↗ |
| May 1, 2025 | Justin Schreiber Chairman and CEO, Director | LFMD LifeMD, Inc. | Sale | 21,995 | $7.53 | $165.6K Sale | Form 4 ↗ |
| Apr 29, 2025 | Justin Schreiber Chairman and CEO, Director | LFMD LifeMD, Inc. | Sale | 50,000 | $7.78 | $389.0K Sale | Form 4 ↗ |
| Mar 14, 2025 | Jessica Friedeman Chief Marketing Officer | LFMD LifeMD, Inc. | Sale | 30,000 | $5.66 | $169.8K Sale | Form 4 ↗ |
| Feb 14, 2025 | Justin Schreiber Chief Executive Officer, Director | LFMD LifeMD, Inc. | Sale | 50,000 | $7.55 | $377.5K Sale | Form 4 ↗ |
| Jan 2, 2025 | Justin Schreiber Chief Executive Officer, Director | LFMD LifeMD, Inc. | Sale | 25,000 | $5.19 | $129.8K Sale | Form 4 ↗ |
| Dec 2, 2024 | Justin Schreiber Chief Executive Officer, Director | LFMD LifeMD, Inc. | Sale | 25,000 | $6.52 | $163.0K Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances